EndoTODAY | EndoATLAS | Outpatient Clinic

Parasite | Esophagus | Stomach | Cancer | ESD

Home | Guide | Author | Subscription | Links


[´ëÇÑ»óºÎÀ§Àå°üÇ︮ÄÚ¹ÚÅÍÇÐȸ Á¦7ȸ Áý´ãȸ]

ÀϽà - 2017³â 2¿ù 13ÀÏ (¿ù), ¿ÀÈÄ 6½Ã 30ºÐ

Àå¼Ò - ¿¬¼¼´ëÇб³ÀÇ°ú´ëÇÐ ¼¼ºê¶õ½ºº´¿ø ¿¬¼¼¾Ïº´¿ø ÁöÇÏ3Ãþ ¼­¾Ï°­´ç (¼­¿ïƯº°½Ã ¼­´ë¹®±¸ ¿¬¼¼·Î 50)


1. Gastric MALToma·Î ÃßÀû°üÂû ÁßÀΠȯÀÚ¿¡¼­ ¹ß»ýÇÑ Á¶±âÀ§¾Ï (¿¬¼¼´ëÇб³ °­³²¼¼ºê¶õ½º º´¿ø)

Two nationwide database study: MALT lymphoma ȯÀÚ¿¡¼­ metachronous adenocarcinomaÀÇ ¹ß»ý·üÀº ³×´ú¶õµå ¿¬±¸¿¡¼­ 6¹è, ¹Ì±¹ ¿¬±¸¿¡¼­ 4.32¹è¿´½À´Ï´Ù.

ÇÔ±â¹é ±³¼ö´Ô Áú¹®: (1) óÀ½¿¡ CLO negative, UBT positive ¿´´Âµ¥ Á¦±ÕÄ¡·á ÈÄ CLO¸¦ ¹Ýº¹ÇÏ¿© °Ë»çÇÒ ÇÊ¿ä°¡ ÀÖ¾ú´Â°¡¿ä? ´Ù¸¥ °Ë»ç´Â ÇÏÁö ¾Ê¾Ò´Â°¡¿ä? (2) Metachronous¶ó°í ¸»Çϱâ´Â ½±Áö ¾Ê½À´Ï´Ù. Helicobacter¶ó´Â common etiology°¡ ÀÖ´Â »óȲÀä... (3) Clonality¿¡ ´ëÇÑ °Ë»ç¸¦ Çß¾î¾ß ÇÏÁö ¾ÊÀ»±î¿ä? Pathognogenomic study°¡ ÇÊ¿äÇß´ø ȯÀÚÀÔ´Ï´Ù. (4) Á¦±ÕÄ¡·á ÈÄ È£ÀüµÇÁö ¾Ê¾Æ¼­ RT aloneÀ¸·Î Ä¡·áÇϼ̴µ¥, B cell targeted therapy¸¦ ÇÏÁö´Â ¾Ê¾Ò´ÂÁö¿ä?


[ÀÌÁØÇà ÇѸ¶µð]

MALT ¸²ÇÁÁ¾Àº Hp Á¦±ÕÄ¡·á ÈÄ È£ÀüµÇ±â±îÁö »ó´çÇÑ ½Ã°£ÀÌ ÇÊ¿äÇÑ ¿¹°¡ ÀÖ½À´Ï´Ù. µå¹°°Ô Áß°£¿¡ ¾ÇÈ­µÇ¾î DLBL ºñ½ÁÇÏ°Ô Ä¡·á Àü·«À» Ç×¾ÏÄ¡·á·Î ¹Ù²ã¾ß ÇÏ´Â °æ¿ìµµ ÀÖ½À´Ï´Ù. ÀϹÝÀûÀÎ À§¾Ï ¹ß»ý·üµµ ´Ù¼Ò ³ô´Ù°í ÇÕ´Ï´Ù. À̹ø Áý´ãȸ¿¡¼­ ³íÀǵǾú´ø »çÇ×À» ¹Ý¿µÇÏ¿© ȯÀÚ ¼³¸í¼­¸¦ ÀϺΠ¹Ù²Ù¾ú½À´Ï´Ù. (last update: 2017-2-15)

"MALT ¸²ÇÁÁ¾Àº À§¾ÏÀÇ ÀÏÁ¾ÀÌÁö¸¸ ¸Å¿ì ƯÀÌÇÑ Á¾·ùÀÔ´Ï´Ù. ºÐ·ù´Â ¾ÏÀ¸·Î µÇ¾îÀÖÁö¸¸ ´ëºÎºÐ (90%) Ç︮ÄÚ¹ÚÅͶó´Â ±Õ°ú ¿¬°üµÇ¾î ÀÖ½À´Ï´Ù. ¼ö¼úÀº ÇÊ¿äÇÏÁö ¾Ê½À´Ï´Ù. Ç︮ÄÚ¹ÚÅÍ °¨¿°À» °¡Áö°í ÀÖ°í À§º®¿¡ ±¹ÇÑµÈ MALT ¸²ÇÁÁ¾Àº Ç×»ýÁ¦¸¦ ÀÌ¿ëÇÏ¿© ±Õ¸¸ Ä¡·áÇϸé 80%¿¡¼­ ¸²ÇÁÁ¾ÀÌ ÃµÃµÈ÷ »ç¶óÁý´Ï´Ù.

Ç×»ýÁ¦¸¦ ÀÌ¿ëÇÑ Á¦±ÕÄ¡·áÀÇ ´ë»óÀÎÁö È®ÀÎÇϱâ À§ÇÏ¿© ¸î °¡Áö °Ë»ç¸¦ ÇÕ´Ï´Ù. °Ë»ç°á°ú´Â ¾à 1ÁÖÀÏ ÈÄ È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù. °Ë»ç °á°ú MALT ¸²ÇÁÁ¾ÀÌ À§º®¿¡¸¸ Á¸ÀçÇÏ°í ´Ù¸¥ ºÎÀ§¿¡ ¹®Á¦°¡ ¾øÀ¸¸é º¸Åë 2ÁÖ Á¤µµÀÇ Åõ¾àÀ» ÇÕ´Ï´Ù. µå¹°°Ô ¾à¹°Ä¡·á¿¡ ¹ÝÀÀÇÏÁö ¾ÊÀ¸¸é ¹æ»ç¼±Ä¡·á³ª Ç×¾ÏÄ¡·á¸¦ ÇÕ´Ï´Ù (20%).

Ç×»ýÁ¦ Ä¡·á ÈÄ MALT ¸²ÇÁÁ¾ÀÌ ¼Ò½ÇµÇ±â±îÁö ¼ö°³¿ù ȤÀº 1³â Á¤µµ °É¸³´Ï´Ù. Åõ¾à ÈÄ ¸î °³¿ù °£°ÝÀ¸·Î ³»½Ã°æ°ú CT µîÀ» °Ë»çÇÕ´Ï´Ù. Áß°£¿¡ ¾ÇÈ­µÇ´Â ¼Ò°ßÀÌ ¾øÀ¸¸é 1³â ȤÀº 1³â¹Ý±îÁö ±â´Ù°í ÀÖ½À´Ï´Ù. º´ÀÌ »ç¶óÁö¸é (ÀÓ»óÀû ¿ÏÀü °üÇØ) 1³â¿¡ 1-2¹ø Á¤µµ °Ë»ç¸¦ ÅëÇÏ¿© Àç¹ßÀº ¾ø´ÂÁö, ´Ù¸¥ Á¾·ùÀÇ À§¾ÏÀº ¾ø´ÂÁö µîÀ» È®ÀÎÇÕ´Ï´Ù."

* Âü°í: EndoTODAY MALToma


2. öºÐ Ä¡·á Áß ºü¸¥ ÁøÇàÀ» º¸ÀÎ À§»óÇÇ ÀÌÇü¼º (°¡Å縯 ´ëÇб³)

Ferrous sulfate º¹¿ë Áß adenoma → EGC → AGCÀÇ progressionÀÌ »¡¶ú´ø Áõ·Ê¿´½À´Ï´Ù.

Speculation: öºÐÀÌ VEGF¿¡ °ü¿©ÇÏ¿© angiogenesis¿¡ ¿µÇâÀ» ¹ÌÄ¡Áö ¾Ê¾ÒÀ»±î? Free radical?


3. ÀþÀº ¿©ÀÚ¿¡¼­ ¹ß°ßµÈ ºñÀüÇüÀûÀÎ À§ »óÇÇÇϺ´º¯ ¹× ÁÖº¯ ÀÓÆļ± Á¾´ë (ºÎ»ê´ë)

À§Ã¼ºÎ È°µ¿¼º ±Ë¾ç ±âÀúºÎ¿¡ Á¡¸·ÇÏÁ¾¾ç ¼Ò°ß. PPI Åõ¿© ÈÄ ±Ë¾çÀº È£ÀüµÇ¾úÀ¸³ª SMT °°Àº º´¼Ò´Â Ä¿Áö´Â ¸ð¾çÀ̾úÀ½

´Ù¹ß¼º left gastric area¿¡ ´Ù¹ß¼º LN°¡ ÀÖ¾úÀ½.

Chest¿¡¼­ Tb lesionÀÌ ÀÖ¾úÀ½. °áÇÙ°Ë»ç´Â ¸ðµÎ nest PCR¿¡¼­ TB°¡ ³ª¿È.

ÇÔ±â¹é ±³¼ö´Ô comment: Anti-tuberculosis Ä¡·á ÈÄ¿¡µµ À§ÀÇ º´¼Ò°¡ ³²ÀÌÀÖ°í ¸²ÇÁÀýÀÌ ÀÛ¾ÆÁø »óÅ·ΠÀ¯ÁöµÇ¹Ç·Î... atypical mycobacterium °¨¿°À» °í·ÁÇÏ´Â °ÍÀÌ ÁÁ°Ú½À´Ï´Ù. Pyrosequencing µîÀÌ µµ¿òµÉ ¼ö ÀÖ°Ú½À´Ï´Ù.

* Âü°í: EndoTODAY Á¡¸·ÇÏÁ¾¾ç

* Âü°í: EndoTODAY °áÇÙ¼º À§ÀåÁúȯ


4. 2016 KSG Satellite Symposium Highlight Kit

ºÎ½ºÀÇ ÇÑ È¸»ç(´ë¿øÁ¦¾à)¿¡¼­ ÀÚ·áÁýÀ» ¹èÆ÷ÇÏ¿´½À´Ï´Ù. ÀåÁø¼® ¼±»ý´Ô°ú ¹®Á¤¼· ¼±»ý´ÔÀÇ °­ÀÇ ÀÚ·á°¡ ÀÖ¾î ¸î Àå ¿Å±é´Ï´Ù.


[References]

1) ´ëÇÑ»óºÎÀ§Àå°üÇ︮ÄÚ¹ÚÅÍÇÐȸ ÇмúÇà»ç Áö»óÁß°è

© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng.